Advertisement
Research Article

E-Peptides Control Bioavailability of IGF-1

  • Marianne Smedegaard Hede equal contributor,

    equal contributor Contributed equally to this work with: Marianne Smedegaard Hede, Ekaterina Salimova

    Affiliation: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy

    X
  • Ekaterina Salimova equal contributor mail,

    equal contributor Contributed equally to this work with: Marianne Smedegaard Hede, Ekaterina Salimova

    ekaterina.salimova@monash.edu (ES); nadia.rosenthal@monash.edu (NR)

    Affiliations: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy, Australian Regenerative Medicine Institute, EMBL Australia/Monash University, Melbourne, Australia

    X
  • Agnieszka Piszczek,

    Affiliation: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy

    X
  • Emarald Perlas,

    Affiliation: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy

    X
  • Nadine Winn,

    Affiliation: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy

    X
  • Tommaso Nastasi,

    Affiliation: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy

    X
  • Nadia Rosenthal mail

    ekaterina.salimova@monash.edu (ES); nadia.rosenthal@monash.edu (NR)

    Affiliations: European Molecular Biology Laboratory (EMBL)-Mouse Biology Unit, Monterotondo, Rome, Italy, Australian Regenerative Medicine Institute, EMBL Australia/Monash University, Melbourne, Australia, National Heart and Lung Institute, Imperial College London, London, United Kingdom

    X
  • Published: December 10, 2012
  • DOI: 10.1371/journal.pone.0051152

Reader Comments (0)

Post a new comment on this article